gsk2838232
Showing 1 - 3 of 3
Infection, Human Immunodeficiency Virus, HIV Trial in Canada, United States (GSK2838232, Cobicistat)
Completed
- Infection, Human Immunodeficiency Virus
- HIV Infections
- GSK2838232
- Cobicistat
-
Birmingham, Alabama
- +13 more
Mar 2, 2020
Infection, Human Immunodeficiency Virus Trial in Baltimore (GSK2838232, Placebo, Ritonavir)
Completed
- Infection, Human Immunodeficiency Virus
- GSK2838232
- +2 more
-
Baltimore, MarylandGSK Investigational Site
May 5, 2017
Infection, Human Immunodeficiency Virus Trial in Baltimore (GSK2838232, Placebo, Ritonavir)
Terminated
- Infection, Human Immunodeficiency Virus
- GSK2838232
- +2 more
-
Baltimore, MarylandGSK Investigational Site
May 5, 2017